Canadian Institutes of Health Research (CIHR)
1,485
238
309
841
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
5.8%
86 terminated/withdrawn out of 1485 trials
90.7%
+4.2% vs industry average
15%
223 trials in Phase 3/4
11%
89 of 841 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1485)
REverse LuNg Airway and Vascular RemOdeling in Asthma ReMission (ReNORM)
Role: collaborator
Weight Loss and Hunger
Role: collaborator
Feasibility of a Diet Intervention for Juvenile Arthritis
Role: collaborator
The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
Role: collaborator
Combined Alcohol and Cannabis Effects on Skills of Young Drivers
Role: collaborator
Finding the Optimal Resistance Training Intensity For Your Bones
Role: collaborator
Evaluation of A Clinical Diagnostic Test for CRDS
Role: collaborator
Smartphone App-Based Mindfulness Intervention for French and English Speaker Cancer Survivors
Role: collaborator
Impact of Metabolic Health Patterns And Breast Cancer Over Time in Women
Role: collaborator
Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)
Role: collaborator
Better Access to and Integration of Mental Health and Addiction Services Through Navigation: A Mixed-Methods Adaptive Pragmatic Clinical Trial
Role: collaborator
Cannabinoids for Osteoarthritis Pain Effectiveness Trial
Role: collaborator
Investigating Metabolic, Brain, and Cognitive Alterations Through Bariatric Surgery
Role: collaborator
Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer
Role: collaborator
Behavioral Intervention and Guided Stepping Training Early Post-Stroke
Role: collaborator
GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
Role: collaborator
Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma
Role: collaborator
Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:
Role: collaborator
Brain-based Prediction of the Dying Duration in Humans After Withdrawal of Life Sustaining Therapies to Inform Donation After Circulatory Death
Role: collaborator
Physical Activity for Adults in the Ontario Breast Screening Program
Role: collaborator